Bigl, Katrin, Gaunitz, Frank, Schmitt, Annett, Rothemund, Sven, Schliebs, Reinhard, Münch, Gerald, and Arendt, Thomas (2008) Cytotoxicity of advanced glycation endproducts in human micro- and astroglial cell lines depends on the degree of protein glycation. Journal of Neural Transmission, 115 (11). pp. 1545-1556.

Schmidt, A., Kuhla, B., Bigl, K., Münch, G., and Arendt, T. (2007) Cell cycle related signalling in neuro2A cells proceeds via the receptor for advanced glycation end products. Journal of Neural Transmission, 114 (11). pp. 1413-1424.

Bigl, Katrin, Schmitt, Annett, Meiners, Ina, Muench, Gerald, and Arendt, Thomas (2007) Comparison of results of the CellTiter Blue, the tetrazolium (3-[4,5-dimethylthioazol-2-yl]-2,5-diphenyl tetrazolium bromide), and the lactate dehydrogenase assay applied in brain cells after exposure to advanced glycation endproducts. Toxicology in Vitro, 21 (5). pp. 962-971.

Kuhla, B, Haase, Cathleen, Flach, Katharina, Luth, Hans-Joachim, Arendt, Thomas, and Muench, Gerald (2007) Effect of pseudophosphorylation and cross-linking by lipid peroxidation and advanced glycation end product precursors on Tau aggregation and filament formation. Journal of Biological Chemistry, 282 (10). pp. 6984-6991.

Kuhla, B, Boeck, Katharina, Schmidt, Angela, Ogunlade, Vera, Arendt, Thomas, Münch, Gerald, and Lüth, Hans-Joachim (2007) Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains. Neurobiology of Aging, 28 (1). pp. 29-41.

Kuhla, Björn , Boeck, Katharina, Lüth, Hans-Joachim, Schmidt, Angela, Weigle, Bernd, Schmitz, Marc, Ogunlade, Vera, Münch, Gerald, and Arendt, Thomas (2006) Age-dependent changes of glyoxalase I expression in human brain. Neurobiology of Aging, 27 (6). pp. 815-822.

Langer, André K., Poon, H. Fai, Münch, Gerald, Lynn, Bert C., Arendt, Thomas, and Butterfield, D. Allan (2006) Identification of AGE-modified proteins in SH-SY5Y and OLN-93 cells. Neurotoxicity Research, 9 (4). pp. 255-268.

Kuhla, Björn, Lüth, Hans-Joachim, Haferburg, Dietrich, Weick, Michael, Reichenbach, Andreas, Arendt, Thomas, and Münch, Gerald (2006) Pathological effects of glyoxalase I inhibition in SH-SY5Y neuroblastoma cells. Journal of Neuroscience Research, 83 (8). pp. 1591-1600.

Kuhla, Björn, Lüth, Hans-Joachim, Haferburg, Dietrich, Boeck, Katharina, Arendt, Thomas, and Münch, Gerald (2005) Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease. Annals of the New York Academy of Sciences, 1043. pp. 211-216.

Richter, Torsten, Muench, Gerald, Luth, Hans-Joachim, Arendt, Thomas, Kientsch-Engel, Rosemarie, Stahl, Peter, Fengler, Dörte, and Kuhla, Björn (2005) Immunochemical crossreactivity of antibodies specific for "advanced glycation endproducts" with "advanced lipoxidation endproducts". Neurobiology of Aging, 26 (4). pp. 465-474.

Luth, Hans-Joachim, Ogunlade, Vera, Kuhla, Björn, Kientsch-Engel, Rosemarie, Stahl, Peter, Webster, Julie, Arendt, Thomas, and Muench, Gerald (2005) Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains. Cerebral Cortex, 15 (2). pp. 211-220.

Webster, Julie, Urban, Christin, Berbaum, Katrin, Loske, Claudia, Alpar, Alan, Gärtner, Ulrich, de Arriba, Susana Garcia, Arendt, Thomas, and Münch, Gerald (2005) The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal. Neurotoxicity Research, 71 (1-2). pp. 95-101.

Wong, A., Luth, H. J., Deuther-Conrad, W., Dukic-Stefanovic, S., Gasic-Milenkovic, J., Arendt, T., and Münch, G. (2001) Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer’s disease. Brain Research, 920 (1-2). pp. 32-40.